Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
Biotech
Health
STAT+
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Adam's Take
STAT+

Maraganore runs away with best biopharma CEO award; Soon-Shiong wins prize for worst

  • Adam Feuerstein

By Adam Feuerstein Dec. 17, 2017

Reprints
Good/Bad CEO 2017
Hyacinth Empinado/STAT

You, the readers of STAT, have spoken. Your votes determined the best and worst biopharma CEOs of 2017.

The Best: John Maraganore of Alnylam Pharmaceuticals. Congratulations, John!

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Adam Feuerstein

Adam Feuerstein

Senior Writer, Biotech

Adam Feuerstein is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He's also a co-host of "The Readout LOUD" podcast.

Tags

Medical device companies now need to prove to FDA…
Medical device companies now need to prove to FDA they’re protected against cyberattacks
Newly available test strips can detect lethal ‘tranq’ in…
Newly available test strips can detect lethal ‘tranq’ in drug supply
Why fentanyl is deadlier than heroin, in a single…
Why fentanyl is deadlier than heroin, in a single photo
New research may give geneticists a long-sought tool: a…
New research may give geneticists a long-sought tool: a targeted protein delivery device
Under pressure, biotech and pharma grapple with how to…
Under pressure, biotech and pharma grapple with how to take action on climate
Oscar Health names former Aetna executive as new CEO
Oscar Health names former Aetna executive as new CEO

  • Hi, Adam. I have followed STAT’s reports on Dr. Soon-Shiong. As a former journalist, I am appalled that he has just bought the LA Times. The horse is probably out of the barn on that sale. But I’m wondering if you guys are planning to circle back and update the tale of his health care boondoggles….

Comments are closed.

Recommended Stories